Deirdre J. Cohen, MD, MS
Deirdre J. Cohen, MD, MS, an expert in pancreatic and other gastrointestinal cancers as well as an accomplished clinical trial leader, has joined Mount Sinai Health System as Director of the Gastrointestinal (GI) Oncology Program and Medical Director of the Cancer Clinical Trials Office at The Tisch Cancer Institute.
Dr. Cohen will also serve as Associate Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. In these roles, she will conduct important translational and clinical research, including studies that build upon scientific discoveries developed at Mount Sinai and collaborating institutions.
As Director of the GI Oncology Program, Dr. -Cohen will foster both clinical and research activities associated with GI cancers across the Mount Sinai cancer sites. She will also oversee the development of clinical trials in her role as Medical Director of the Cancer Clinical Trials Office. Dr. Cohen has abundant experience as principal investigator on numerous trials for novel therapeutic approaches for gastrointestinal cancer in particular.
“We are very proud that Dr. Cohen has decided to join us to help lead our efforts in gastrointestinal cancers,” said Ramon Parsons, MD, PhD, Director of The Tisch Cancer Institute at Mount Sinai, Chair of Oncological Sciences, and Ward-Coleman Professor in Cancer Research of the Icahn School of Medicine at Mount Sinai. “We are excited to welcome her to also further develop our already robust clinical trial office.”
Dr. Cohen’s Education and Experience
Prior to joining Mount Sinai, Dr. Cohen was on the faculty in the Division of Medical Oncology at New York University (NYU) for 13 years. Recently, she served as Medical Director for the Perlmutter Cancer Center Clinical Trials Office and as Acting Director of NYU GI Medical Oncology. Board certified in internal medicine, medical oncology, and hematology, Dr. Cohen is a member of the American Society of Clinical Oncology and the National Cancer Institute Colon Task Force.
Dr. Cohen received her medical degree from the State University of New York Health Science Center at Brooklyn and a Master of Science in Clinical Investigation from New York University. She completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center and a fellowship in hematology/oncology at NYU Langone School of Medicine.
“Dr. Cohen’s arrival is an exciting step forward for coordinating a multidisciplinary approach for gastrointestinal cancer that builds on a strong foundation already here,” said William K. Oh, MD, Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute at Mount Sinai and the Ezra M. Greenspan, MD, Professor in Clinical Cancer Care Therapeutics. “We are driven to continue to develop more effective therapies in trials for a constellation of cancers that take so many lives every year.”
